Legal status of psilocybin mushrooms

From WikiMD's WELLNESSPEDIA

Legal status of psilocybin mushrooms‏‎

The legal status of psilocybin mushrooms‏‎ varies worldwide. Psilocybin mushrooms, also known as magic mushrooms, are a group of fungi that contain the psychoactive compounds psilocybin and psilocin. These mushrooms have been used in various cultures for religious rites and healing practices, and have recently been studied for their potential therapeutic effects in treating mental health conditions such as depression and post-traumatic stress disorder (PTSD).

Legality by country[edit]

United States[edit]

In the United States, psilocybin is classified as a Schedule I drug under the Controlled Substances Act, making it illegal to manufacture, buy, possess, or distribute without a license from the Drug Enforcement Administration (DEA). However, some cities and states have decriminalized psilocybin to varying degrees.

Canada[edit]

In Canada, psilocybin is classified as a Schedule III drug under the Controlled Drugs and Substances Act, making it illegal to produce, distribute, or possess. However, exemptions have been granted for religious and medical use.

United Kingdom[edit]

In the United Kingdom, psilocybin mushrooms are classified as a Class A drug under the Misuse of Drugs Act 1971, making it illegal to produce, supply, or possess. However, the law does not cover the cultivation of psilocybin mushrooms for personal use.

Medical use and research[edit]

Despite their legal status, psilocybin mushrooms have been the subject of medical research due to their potential therapeutic effects. Studies have shown that psilocybin can have positive effects on mental health conditions such as depression and PTSD, leading to calls for a reevaluation of its legal status.

See also[edit]

Psychoactive substance-related disorders
General
Combined
substance use
Alcohol
Caffeine
Cannabis


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Legal status of psilocybin mushrooms[edit]

  • Map showing the legality of psilocybin mushrooms
    Map showing the legality of psilocybin mushrooms

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Legal_status_of_psilocybin_mushrooms&oldid=6307191"